Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | January 6, 2015 |
| Target | OnCyte |
| Sector | Life Science |
| Buyer(s) | Celyad Oncology |
| Sellers(s) | Celdara Medical |
| Deal Type | Divestiture |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2004 |
| Sector | Life Science |
| Employees | 17 |
| Revenue | 3M EUR (2018) |
Celyad Oncology is a biopharmaceutical company, focused on the discovery, development and commercialization of regenerative and protective therapies for cardiovascular diseases. Celyad Oncology was incorporated in 2004 and is based in Mont-Saint-Guibert, Belgium.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: United States | 2 of 2 |
| Year: 2015 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-11-05 |
CorQuest Medical
Miami, Florida, United States CorQuest Medical specializes in the development of innovative devices and technologies for cardiac surgery. CorQuest’s revolutionary technology is designed to enable cardiologists to take a unique access route directly to the patient’s left atrium. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 2008 |
| Sector | Life Science |
Celdara Medical builds academic and early-stage innovations into high-potential medical companies, identifying discoveries of exceptional value at the earliest stages and moving them toward the market.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2015 | 1 of 1 |
